Abstract
ObjectivesThe response to glucagon-like peptide-1 (GLP-1) analogues for weight loss varies significantly. We investigated the anthropometric, demographic and clinical characteristics associated with total body weight loss (TBWL) from subcutaneous GLP-1...
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have